Takeda announced that Costa Saroukos, chief financial officer, has decided to leave Takeda to return to his home-country of Australia to be closer to family. Saroukos will step down as CFO, effective April 1 and will remain with the company as a board director until June 28. Milano Furuta, president of Takeda’s Japan Pharma Business Unit, or JPBU, will succeed Saroukos, effective April 1. Furuta will report to Christophe Weber, president & CEO, and will be based in Tokyo, Japan. As CFO, Furuta will be proposed to the board of directors as a candidate for election to the board.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on TAK: